European Pharmaceutical Review

DECEMBER 14, 2023

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. But over time, trends in what evidence is most available and therefore most used, change.

Medicine 111

Medicine Safety Competition Networking 111

European Pharmaceutical Review

JULY 20, 2022

Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Six products were withdrawn or revoked for safety reasons during the study period.

Medicine 77

Medicine Safety Side effects Electronics 77

PharmaKinnex

AUGUST 23, 2022

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. More convenience and safety? Fewer Networking & Industry Trade Show Events. Hiring, training, and managing sales representatives were never cheap. August 23, 2022. dstansberry@costellocreativegroup.com.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

MAY 20, 2024

5,6 Clinical trials are essential for the safety and efficacy of novel therapies to be established. In fact, one-quarter of rare disease trials between 2016 and 2020 were terminated due to low accrual rates.

Patients 117

Patients Medical Safety Healthcare 117

PM360

MAY 15, 2023

In addition, IBM will be preparing Moderna’s scientists to use its technology, with the company participating in the IBM Quantum Accelerator program and the IBM Quantum Network through which access to IBM’s quantum computing systems can assist Moderna in exploring life sciences use cases powered by quantum technologies.

Safety 52

Safety Healthcare Healthcare Electronics 52